Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2022	Dec. 31, 2021
ASSETS
Cash and cash equivalents	$ 284,820	$ 385
Accounts receivable	0	37,638
Total Assets	284,820	38,023
Current Liabilities:
Accounts payable	392,253	65,853
Accrued expenses	286	286
Accrued interest	1,183,742	18,602
Accrued officer compensation	1,069,074	556,394
Convertible Notes	286,210	84,681
Put premium on stock settled debt	159,684	0
Derivative liability	0	110,992
Deferred revenue	0	3,108
Loans payable, current portion	257,185	0
Total Current Liabilities	3,348,434	839,916
Loans payable, net of current portion	306,815	40,401
Total Liabilities	3,655,249	880,317
Commitments and Contingencies (Note 13)
STOCKHOLDERS' DEFICIT:
Series A Preferred stock, 3,500,000 shares authorized, par value $0.01; 3,381,520 and 0 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively	33,815	0
Series B Preferred stock, 10,000 shares authorized, par value $0.01; 5,000 and 0 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively	50	0
Series C Preferred stock, 10,000,000 shares authorized, par value $0.01; 5,000,000 and 0 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively	50,000	0
Series D Preferred stock, 125,000 shares authorized, par value $0.0001; 125,000 and 0 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively	12	0
Series E Preferred stock to be issued	166,331	0
Series F Preferred stock, 101 shares authorized, par value $0.0001; 101 and 0 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively	0	0
Series G Preferred stock, 1,000,000 shares authorized, par value $0.0001; 1,000,000 and 0 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively	1,000	0
Series AA Preferred stock, 10,000,000 shares authorized, par value $0.0001; 0 and 652,259 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively	0	652
Series Super Preferred stock, 10,000,000 shares authorized, par value $0.0001; 0 and 500 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively	0	1
Common stock 20,000,000,000 shares authorized, $0.00001 par value; 15,628,974,812 and 18,150,000 shares issued and outstanding, respectively at June 30, 2022 and December 31, 2021	156,290	18,150
Common stock to be issued, 2,550,000 and 0 shares as of June 30, 2022 and December 31, 2021, respectively	26	0
Treasury stock, at cost – 2,917 shares and 0 shares as of June 30, 2022 and December 31, 2021, respectively	(773,500)	0
Additional paid in capital	2,010,091	3,802,391
Accumulated deficit	(5,014,544)	(4,663,488)
Total Stockholders' Deficit	(3,370,429)	(842,294)
Total Liabilities and Stockholders' Deficit	$ 284,820	$ 38,023